Patent · US Active

Methods of use of epsilon inhibitor compounds for the attenuation of pain

US8492346B2 · kind B2 · utility

0Cited by

20References

17Claims

0Family size

Assignee

KAI PHARMACEUTICALS, INC. · US

Inventors

Derek Maclean · Los Altos, US
Qun Yin · Palo Alto, US

Key dates

Filing date	Sep 12, 2011
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Sep 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure herein relates to modified εPKC inhibitory peptides, methods of generating such peptides, and method for using εPKC inhibitory peptides for the treatment of pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.